Article info

Download PDFPDF
QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?

Authors

  • Nadia Laila Amin Department of Paediatric Endocrinology, Leeds General Infirmary, Leeds, West Yorkshire, UK Department of Paediatric Haematology and Oncology, Leeds Teaching Hospitals NHS Trust, York, UK PubMed articlesGoogle scholar articles
  • Rebecca M James Department of Paediatric Haematology and Oncology, Leeds Teaching Hospitals NHS Trust, York, UK PubMed articlesGoogle scholar articles
  • Robert Phillips Department of Paediatric Haematology and Oncology, Leeds Teaching Hospitals NHS Trust, York, UK Centre for Reviews and Dissemination, York, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nadia Laila Amin, Department of Paediatric Haematology and Oncology, Leeds Children's Hospital, Leeds, West Yorkshire LS1 3EX, UK; nadia{at}cantab.net
View Full Text

Citation

Amin NL, James RM, Phillips R
QUESTION 1: Should we be using bisphosphonates for osteonecrosis complicating childhood acute lymphoblastic leukaemia?

Publication history

  • Received October 9, 2015
  • Revised December 4, 2015
  • Accepted December 16, 2015
  • First published January 14, 2016.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.